Aspirin increases upper GI bleeding for older people

Research scheduled to be presented at the cancelled Digestive Disease Week conference in Chicago, USA in early May 2020 has assessed of specific aspect of safety data on on over 19,000 patients in the famous Aspree study, where just over 9,500 patients were assigned...

SGLT2 inhibitors reduce the risk of adverse renal events

The effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on renal outcomes in routine clinical practice have been investigated in a Scandinavian cohort study. 29,887 new users of SGLT2 inhibitors (such as dapagliflozin, empagliflozin and canagliflozin) were...

Adverse drug reactions amongst COVID-19 patients  

A new retrospective analysis of the incidence, type and risk factors associated with adverse drug reactions (ADRs) in COVID-19 patients has been published from China. The study used active monitoring of the China Hospital Pharmacovigilance System (CHPS) to detect ADR...